The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Ken Hall looks at three important considerations for investors looking to build a sizeable passive income for a better financial future.

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-12-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2089.50. On previous day, the ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

In an exclusive interview with SheKnows, Brooke Shields talked about aging, health, and how she talks about all of this with ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...